Table 4.
Exosome-derived miR125b-3p, miR-122-5p and miR-205-5p with significantly differential expression in pancreatic cancer patients and healthy controls, divided according to cancer type, ancestry, tumor progression, and survival status.
| miR-125b-3p | miR-122-5p | miR-205 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pancreatic Cancer Type | Pancreatic Cancer Type | Pancreatic Cancer Type | Ancestry | Tumor Progression | Survival Status | ||||||||||
| Control | Adeno | Other | Control | Adeno | Other | Control | Adeno | Other | African | European | No | Yes | Alive | Dead | |
| Samples | 73 | 38 | 12 | 78 | 47 | 18 | 65 | 39 | 14 | 17 | 36 | 36 | 17 | 35 | 18 |
| Mean | 1.41 | 5.32 | 2.50 | 1.55 | 7.78 | 2.13 | 5.09 | 21.04 | 9.96 | 12.32 | 20.85 | 11.31 | 32.53 | 10.95 | 32.05 |
| Standard Error of Mean | 0.18 | 0.95 | 0.90 | 0.38 | 2.51 | 0.71 | 1.67 | 5.95 | 2.80 | 2.62 | 6.45 | 1.66 | 13.08 | 1.72 | 12.31 |
| Lower 95% CI | 1.06 | 3.40 | 0.52 | 0.79 | 2.74 | 0.63 | 1.75 | 8.99 | 3.90 | 6.77 | 7.75 | 7.94 | 4.80 | 7.46 | 6.08 |
| Upper 95% CI | 1.77 | 7.24 | 4.47 | 2.30 | 12.82 | 3.62 | 8.43 | 33.09 | 16.01 | 17.86 | 33.95 | 14.68 | 60.25 | 14.43 | 58.02 |
| p-value | 0.0001 | 0.9616 | 0.0451 | 0.9998 | 0.0301 | 0.9895 | 0.8992 | 0.0404 | 0.8378 | 0.0024 | 0.9412 | 0.0038 | |||